594 related articles for article (PubMed ID: 27470222)
1. A review of semi-synthetic biopolymer complexes: modified polysaccharide nano-carriers for enhancement of oral drug bioavailability.
Sithole MN; Choonara YE; du Toit LC; Kumar P; Pillay V
Pharm Dev Technol; 2017 Mar; 22(2):283-295. PubMed ID: 27470222
[TBL] [Abstract][Full Text] [Related]
2. Drug Release from Porous Matrixes based on Natural Polymers.
Kaczmarek B; Sionkowska A
Curr Pharm Biotechnol; 2017; 18(9):721-729. PubMed ID: 29110601
[TBL] [Abstract][Full Text] [Related]
3. Recent development of chitosan-based polyelectrolyte complexes with natural polysaccharides for drug delivery.
Luo Y; Wang Q
Int J Biol Macromol; 2014 Mar; 64():353-67. PubMed ID: 24360899
[TBL] [Abstract][Full Text] [Related]
4. Biopolymer nano-particles and natural nano-carriers for nano-encapsulation of phenolic compounds.
Faridi Esfanjani A; Jafari SM
Colloids Surf B Biointerfaces; 2016 Oct; 146():532-43. PubMed ID: 27419648
[TBL] [Abstract][Full Text] [Related]
5. Polysaccharides based nanomaterials for targeted anti-cancer drug delivery.
Dheer D; Arora D; Jaglan S; Rawal RK; Shankar R
J Drug Target; 2017 Jan; 25(1):1-16. PubMed ID: 27030377
[TBL] [Abstract][Full Text] [Related]
6. Applications of Natural Polymeric Materials in Solid Oral Modified-Release Dosage Forms.
Li L; Zhang X; Gu X; Mao S
Curr Pharm Des; 2015; 21(40):5854-67. PubMed ID: 26446465
[TBL] [Abstract][Full Text] [Related]
7. Novel prospective in colon specific drug delivery system.
Bansal V; Malviya R; Malaviya T; Sharma PK
Polim Med; 2014; 44(2):109-18. PubMed ID: 24967782
[TBL] [Abstract][Full Text] [Related]
8. Natural and synthetic poly(malic acid)-based derivates: a family of versatile biopolymers for the design of drug nanocarriers.
Loyer P; Cammas-Marion S
J Drug Target; 2014 Aug; 22(7):556-75. PubMed ID: 25012064
[TBL] [Abstract][Full Text] [Related]
9. Polymeric particulate technologies for oral drug delivery and targeting: a pathophysiological perspective.
Hunter AC; Elsom J; Wibroe PP; Moghimi SM
Nanomedicine; 2012 Sep; 8 Suppl 1():S5-20. PubMed ID: 22846372
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of Oral Bioavailability of Protein and Peptide by Polysaccharide-based Nanoparticles.
Islam MM; Raikwar S
Protein Pept Lett; 2024; 31(3):209-228. PubMed ID: 38509673
[TBL] [Abstract][Full Text] [Related]
11. Nanostructured lipid (NLCs) carriers as a bioavailability enhancement tool for oral administration.
Gaba B; Fazil M; Ali A; Baboota S; Sahni JK; Ali J
Drug Deliv; 2015; 22(6):691-700. PubMed ID: 24670099
[TBL] [Abstract][Full Text] [Related]
12. Polymer-based nanoparticles for oral insulin delivery: Revisited approaches.
Fonte P; Araújo F; Silva C; Pereira C; Reis S; Santos HA; Sarmento B
Biotechnol Adv; 2015 Nov; 33(6 Pt 3):1342-54. PubMed ID: 25728065
[TBL] [Abstract][Full Text] [Related]
13. Polymeric nanoparticles for oral delivery of drugs and vaccines: a critical evaluation of in vivo studies.
Galindo-Rodriguez SA; Allemann E; Fessi H; Doelker E
Crit Rev Ther Drug Carrier Syst; 2005; 22(5):419-64. PubMed ID: 16313233
[TBL] [Abstract][Full Text] [Related]
14. Multifunctional Delivery Systems for Advanced oral Uptake of Peptide/Protein Drugs.
Park JW; Kim SJ; Kwag DS; Kim S; Park J; Youn YS; Bae YH; Lee ES
Curr Pharm Des; 2015; 21(22):3097-110. PubMed ID: 26027575
[TBL] [Abstract][Full Text] [Related]
15. Polysaccharide Encrusted Multilayered Nano-Colloidal System of Andrographolide for Improved Hepatoprotection.
Mishra N; Yadav KS; Rai VK; Yadav NP
AAPS PharmSciTech; 2017 Feb; 18(2):381-392. PubMed ID: 27007741
[TBL] [Abstract][Full Text] [Related]
16. Development of a Novel Polymeric Nanocomposite Complex for Drugs with Low Bioavailability.
Sithole MN; Choonara YE; du Toit LC; Kumar P; Marimuthu T; Kondiah PPD; Pillay V
AAPS PharmSciTech; 2018 Jan; 19(1):303-314. PubMed ID: 28717975
[TBL] [Abstract][Full Text] [Related]
17. Levan-based nanostructured systems: An overview.
de Siqueira EC; Rebouças JS; Pinheiro IO; Formiga FR
Int J Pharm; 2020 Apr; 580():119242. PubMed ID: 32199961
[TBL] [Abstract][Full Text] [Related]
18. Pharmaceutical development and regulatory considerations for nanoparticles and nanoparticulate drug delivery systems.
Narang AS; Chang RK; Hussain MA
J Pharm Sci; 2013 Nov; 102(11):3867-82. PubMed ID: 24037829
[TBL] [Abstract][Full Text] [Related]
19. pH-sensitive polymeric nanoparticles to improve oral bioavailability of peptide/protein drugs and poorly water-soluble drugs.
Wang XQ; Zhang Q
Eur J Pharm Biopharm; 2012 Oct; 82(2):219-29. PubMed ID: 22885229
[TBL] [Abstract][Full Text] [Related]
20. Polymeric micelles for oral drug delivery.
Gaucher G; Satturwar P; Jones MC; Furtos A; Leroux JC
Eur J Pharm Biopharm; 2010 Oct; 76(2):147-58. PubMed ID: 20600891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
